Precision Genomic Testing Market Report Examines Industry Trends, Growth Drivers And Future Outlook

The precision genomic testing market is poised for remarkable growth, driven by technological advances and expanding clinical applications. This sector is becoming increasingly essential as healthcare moves toward more personalized and precise treatment approaches. Below, we explore the market's anticipated size, key players shaping the field, emerging trends, and the important segments that define this dynamic industry.

Projected Expansion of the Precision Genomic Testing Market by 2030
The precision genomic testing market is forecasted to experience substantial growth, reaching a valuation of $25.71 billion by 2030. This expansion reflects a compound annual growth rate (CAGR) of 11.3%. Several factors contribute to this upward trajectory, including the widespread adoption of precision medicine, increased funding for genomic research, the scaling up of population-wide genomic programs, and growing demand for companion diagnostics. Moreover, genomics is becoming more routinely integrated into clinical workflows. Key trends during this period include the rising use of next-generation sequencing (NGS), AI-enhanced genomic data interpretation, a surge in personalized therapy planning, growth in clinical genomic testing, and the deeper incorporation of bioinformatics tools.

The precision genomic testing market size has grown rapidly in recent years. It will grow from $15 billion in 2025 to $16.75 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to advancements in sequencing technologies, expansion of precision oncology programs, increasing availability of genomic databases, growth in clinical research funding, rising awareness of genetic disorders.

Download a free sample of the precision genomic testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25883&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Organizations Advancing the Precision Genomic Testing Market
Prominent companies at the forefront of the precision genomic testing landscape include Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Ambry Genetics Corporation, Color Health Inc., Pacific Biosciences, Eurofins Genomics LLC, and BGI Genomics Co. Ltd.
A significant development occurred in May 2025 when QIAGEN N.V., based in the Netherlands, acquired Genoox Ltd., an Israeli firm specializing in cloud-based AI genomic platforms. This acquisition aims to bolster QIAGEN's clinical genomics offerings by incorporating Genoox's AI-driven variant interpretation technology, which accelerates and improves the accuracy of genomic insights for hereditary conditions, oncology, and other clinical applications.

Emerging Innovations Shaping the Precision Genomic Testing Sector
Industry leaders are emphasizing the development of cutting-edge solutions such as ultra-sensitive circulating tumor DNA (ctDNA) assays, which detect minute tumor-derived DNA fragments in blood samples. These assays enable the earlier and more precise identification of cancer-related genetic mutations, thereby improving patient outcomes.
For example, in April 2025, Natera Inc., a US-based clinical genetics company, launched the Signatera test, an ultra-sensitive genome molecular residual disease assay. This test employs whole genome sequencing of both a patient's tumor and matched normal DNA to create a personalized assay capable of detecting ctDNA at extremely low levels-down to one part per million. This unparalleled sensitivity facilitates earlier and more accurate detection of cancer recurrence, aiding in optimized treatment strategies across multiple cancer types.

View the full precision genomic testing market report:
https://www.thebusinessresearchcompany.com/report/precision-genomic-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Detailed Segmentation in the Precision Genomic Testing Market
The market report categorizes precision genomic testing into several key segments:
1) Product and Service Categories: Consumables, Equipment, and Services
2) Technology Types: Next-Generation Sequencing, Polymerase Chain Reaction (PCR), Microarray Technology, Sanger Sequencing, CRISPR and CRISPR-Associated Systems, plus other technologies
3) Applications: Oncology, Cardiovascular Diseases, Neurological Disorders, Reproductive Health, Rare Diseases, and additional applications
4) End-User Groups: Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes, and other end-users

Further subcategories include:
- Consumables: Reagents and Kits, DNA/RNA Extraction Kits, Library Preparation Kits, Sequencing Reagents, PCR Assay Kits, Buffers, and Enzymes
- Equipment: NGS Systems, PCR Machines, Microarray Instruments, DNA Analyzers, Bioinformatics Workstations, Laboratory Automation Systems
- Services: Genomic Data Analysis, Laboratory Testing, Genetic Counseling, Clinical Interpretation, Contract Research, and Customized Assay Development

This comprehensive segmentation highlights the diverse components and applications that constitute the precision genomic testing industry, illustrating its complexity and the breadth of opportunities it offers moving forward.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.